Latest filing published 03 Sept 2026 for NIKE, Inc..
David M. Denton appears at 5 companies, nearly always as chief financial officer: CVS Health Corp (EVP and CFO, 25 filings), Lowes Companies Inc (EVP, Chief Financial Officer, 8), Pfizer Inc (Chief Financial Officer & EVP, 3) and NIKE, Inc. (EVP: CFO, 1), plus a Director seat at a fifth company (7 filings). The record counts 44 filings published from March 2, 2016 to September 3, 2026.
The 6 sales, all at CVS Health Corp, total EUR 41.3 million for a median of EUR 7,100,302, which makes them large trades. The largest, EUR 16,470,585, is dated June 12, 2017, followed by EUR 7,292,634 on March 10, 2017 and EUR 7,202,290 on September 11, 2017. No purchase is recorded. There are also 29 grants, 6 option exercises and 3 other filings.
2017 gathers 16 filings; 2021, 2023, 2024 and 2026 have one each. One filing falls in the last twelve months.
Denton has 4, 4 and 3 own market trades within 30 days of colleagues at CVS HEALTH Corp, in that order. All on the same side. The colleagues, in the same order: Helena Foulkes, Jonathan C. Roberts and Larry J. Merlo. Filings appear a median of 2 days after the trade.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 44 declarations